SPRINGWORKS THERAPEUTICS INC (SWTX)
US85205L1070 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -339.07M | -325.10M | -277.42M | -173.91M | -45.57M | |||
| Depreciation Amortization | 2.15M | 1.67M | 770.00K | 490.00K | 350.00K | |||
| Change In Working Capital | -11.13M | -583.00K | 38.10M | 5.12M | 1.35M | |||
| Other non cash items | 108.15M | 101.22M | 76.99M | 40.43M | 11.69M | |||
| OPERATING CASH FLOW | -239.91M | -222.79M | -161.56M | -127.88M | -32.19M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -4.98M | -7.38M | -10.20M | -2.02M | -640.00K | |||
| Other Investing Activity | -37.40M | 42.14M | -205.40M | 85.61M | -418.19M | |||
| INVESTING CASH FLOW | -42.38M | 34.75M | -215.60M | 83.59M | -418.83M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 297.94M | 296.64M | 340.70M | 1.16M | 270.49M | |||
| FINANCING CASH FLOW | 297.94M | 296.64M | 340.70M | 1.16M | 270.49M | |||
| CHANGE IN CASH | 15.65M | 108.60M | -36.46M | -43.13M | -180.53M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -239.91M | -222.79M | -161.56M | -127.88M | -32.19M | |||
| Capital Expenditure | -4.98M | -7.38M | -10.20M | -2.02M | -640.00K | |||
| FREE CASH FLOW | -244.89M | -230.18M | -171.76M | -129.90M | -32.83M | |||
All data in USD